Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 17.3. Anti-inflammatory medicines |
Others observations: Therapeutic alternative: mesalazine |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 17.3. Anti-inflammatory medicines |
Others observations: Therapeutic alternative: mesalazine |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 17.3. Anti-inflammatory medicines |
Others observations: Therapeutic alternative: mesalazine |
| Peru | 17.3 Anti-Inflammatories | No observations |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 06.7 Digestive Disorders | No observations |
| WHO Model List of Essential Medicines (2021) | 29.2. Disease-modifying anti-rheumatic drugs (DMARDs) | No observations |